UroGen Pharma Ltd. Cash Flow Statement

Cash Flow Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Depreciation and Depletion 0.11M0.21M0.21M
Share-based Compensation 0.45M1.97M6.30M30.64M29.97M28.02M23.11M10.58M9.34M13.11M
Gains from Sales and Divestitures 0.12M0.12M0.18M0.09M0.28M0.37M0.29M0.39M
Gains from Investment Securities 0.24M2.74M0.59M1.20M0.96M0.40M0.59M0.41M1.01M0.20M
Asset Writedowns and Impairment 0.87M
Non-cash Items 14.13M26.50M30.80M13.50M2.15M1.91M5.13M1.09M
Cash from Operations -7.17M4.19M-9.57M-37.33M-71.02M-105.89M-84.89M-87.56M-76.38M-96.77M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.03M1.63M0.94M1.75M1.03M2.89M
Amortization of Deferred Charges 1.03M1.63M
Depreciation & Amortization (CF) 0.11M0.21M0.21M0.42M0.30M0.42M0.83M0.92M0.80M0.33M
Change in Working Capital
Change in Receivables 0.08M-0.08M7.05M4.67M0.99M2.74M4.86M
Change in Inventory 0.10M0.21M-0.32M1.96M2.87M0.36M1.35M3.55M
Change in Accured Expenses 1.16M0.48M2.53M4.21M2.93M2.84M-2.61M1.31M4.16M10.89M
Change in Taxes 0.66M
Other Working Capital Changes 0.74M-0.74M0.65M-0.65M0.39M2.33M4.11M3.63M-0.82M-1.44M
Investing Activities
Capital Expenditures 0.30M0.69M0.27M0.56M0.33M1.22M0.75M0.25M0.19M0.29M
Change in Acquisitions & Divestments 36.00M-35.90M52.59M124.14M54.26M64.32M49.07M107.70M
Cash from Investing Activities -0.30M-0.72M-36.28M35.29M-145.59M93.24M4.07M1.06M-0.95M-20.61M
Financing Activities
Other financing activities 0.58M0.04M0.21M0.08M0.07M0.14M0.16M
Cash from Financing Activities 21.58M-0.01M61.59M66.42M165.25M16.53M72.32M97.13M116.93M194.62M
Additional items
Change in Cash 14.11M3.46M15.74M64.37M-51.36M3.88M-8.50M10.63M39.60M77.24M
Free Cash Flow -7.48M3.49M-9.84M-37.89M-71.34M-107.10M-85.64M-87.81M-76.57M-97.06M
Net Cash Flow 14.11M3.46M15.74M64.37M-51.36M3.88M-8.50M10.63M39.60M77.24M